Investment Summary

Accelmed Invests In Corvia Medical

On July 1, 2014, private equity firm Accelmed invested in medical products company Corvia Medical

Investment Highlights
  • This is Accelmed’s 2nd transaction in the Medical Products sector.
  • This is Accelmed’s 1st transaction in the United States.
  • This is Accelmed’s 1st transaction in Massachusetts.

Investment Summary
Date 2014-07-01
Target Corvia Medical
Sector Medical Products
Investor(s) Accelmed
Deal Type Venture

Target

Corvia Medical

Tewksbury, Massachusetts, United States
Corvia Medical is a developer of the first transcatheter device to treat congestive heart failure (CHF). The company’s innovative IASD™ (InterAtrial Shunt Device) System is designed to relieve increased left atrial pressure. Corvia Medical was founded in 2009 and is based in Tewksbury, Massachusetts.

Search 201,157 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Investor(S) 1

Investor

Accelmed

Investor Investor Investor Investor Investor

Category Private Equity Firm
Founded 2009
Size Small
Type Sector Focused
DESCRIPTION

Accelmed is a global investment firm focused on providing investments in small and mid-cap private and public companies. The Firm looks to invest between $20 and $50 million in medical device companies and technologies with revenues between $20 and $70 million. Prospective transaction types include management buyouts and growth financings. Accelmed was formed in 2009 and is based in Miami, Florida.

DEAL STATS #
Overall 2 of 18
Sector (Medical Products) 2 of 12
Type (Venture) 1 of 8
State (Massachusetts) 1 of 3
Country (United States) 1 of 14
Year (2014) 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2012-07-11 Valcare Medical

Herzliya, Israel

Valcare Medical is dedicated to providing innovative minimally-invasive technologies for the treatment of mitral and tricuspid regurgitation including repair and replacement devices. Valcare Medical was founded in 2012 and is based in Herzliya, Israel.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2015-04-01 Digma Medical

Givat Shmuel, Israel

Digma Medical is the developer of a minimally invasive therapy, Endoscopic Glycemic Management (EGM), that aims to restore the body’s natural ability to control blood glucose levels in patients with Type 2 diabetes. Digma Medical was founded in 2013 and is based in Givat Shmuel, Israel.

Buy -
Mergr

Product

Company

Legal